Background: Classical Laron syndrome is a recessive disease of primary insulin-like growth factor 1 (IGF-1) deficiency and primary growth hormone insensitivity. Affected children have, among other defects, sparse hair growth and frontal recessions. The hair is thin and easy to pluck. Young adults have various degrees of alopecia, more pronounced in males. Objective: The aim of the present study was to investigate the effect of primary IGF-1 deficiency on hair structure. The study sample included 11 patients with Laron syndrome – 5 children (2 untreated) and 6 adults (5 untreated). Hairs were examined by light and electron microscopy. Results: The most significant structured defect, pili torti et canaliculi, was found in 2 young, untreated patients. Grooving, tapered hair and trichorrhexis nodosa were found in the remainder. IGF-1-treated patients had either none or significantly fewer pathological changes compared to the untreated patients. Conclusion: This is the first documentation of the role of primary IGF-1 deficiency on hair structure in human beings.

Keywords:
Insulin-like growth factor, Hair structure defect, Laron syndrome
1.
Laron Z, Pertzelan A, Manheimer S: Genetic pituitary dwarfism with high serum concentration of growth hormone: A new inborn error of metabolism? Isr J Med 1966;2:153–155.
2.
Laron Z: Laron syndrome – Primary growth hormone resistance; in Jameson JL (ed): Contemporary Endocrinology, Hormone Resistance Syndromes. Totowa, Human Press, 1999, vol 2, pp 17–37.
3.
Laron Z: Growth hormone insensitivity (Laron syndrome). Rev Endocr Metab Disord 2002;3:347–355.
4.
Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Rev 1994;15:369–390.
5.
Laron Z, Klinger B, Grunebaum M: Laron type dwarfism: Special feature – Picture of the month. Am J Dis Child 1991;145:473–474.
6.
Laron Z: Natural history of classical form of primary growth hormone (GH) resistance (Laron syndrome). J Pediatr Endocrinol Metab 1999;12:231–249.
7.
Merimee T, Laron Z: Growth hormone, IgF-I and growth: New views of old concepts; in Modern Endocrinology and Diabetes. London, Freund Publishing House Ltd, 1996, vol 4.
8.
Laron Z: Somatomedin-1 (recombinant insulin-like growth factor-1): Clinical pharmacology and potential treatment of endocrine and metabolic disorders. Biodrugs 1999;11:55–70.
9.
Zapf J, Froesch ER: Insulin-like growth factor 1 actions on somatic growth; in Kostyo K (ed): Handbook of Physiology. New York, American Physiological Society 1999, vol 5, pp 663–669.
10.
Clemmons DR, Underwoof LE: Nutritional regulation of IGF-1 and IFG binding proteins. Annu Rev Nutr 1991;11:393–412.
11.
Zapf J, Gosteli-Peter M, Schmid C: Insulin-like growth factor binding proteins (GFBPs) – Growth hormone, IGF-I and growth: New views of old concepts; in Merimee T, Laron Z (eds): Modern Endocrinology and Diabetes. London, Freund Publishing House, Ltd., 1996, vol 4, pp 45–71.
12.
Peus D, Pittlekow MR: Growth factors in hair organ development and the hair growth cycle. Dermatol Clin 1996;14:559–572.
13.
Stenn KS, Combates NJ, Eilersten KJ, et al: Hair follicle growth controls. Dermatol Clin 1996;14:543–558.
14.
Philpott MP, Sanders DA, Kealey T: Effects of insulin-like growth factors on cultured human hair follicles: IGF-I at physiological concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 1994;102:857–861.
15.
Harris PM, McBride BW, Gurnsey MP, et al: Direct infusion of a variant of insulin-like growth factor-I into skin of sheep and effects on local blood flow, amino acid utilisation and cell replication. J Endocrinol 1993;139:463–472.
16.
Bol DK, Kiguchi K, Gimenezconti I, et al: Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities and spontaneous tumor formation in transgenic mice. Oncogene 1997;14:1725–1734.
17.
Orwin DFG, Woods JL, Elliott KH: Composition of the cortex of sound and tender wools. J Text Inst 1980;71:315–317.
18.
Su HY, Hickford JG, Bickerstaffe R, Palmer BR: Insulin-like growth factor I and hair growth. Dermatol Online 1999;5:1.
19.
Laron Z, Shevah O, Rubinstein M: Similarity of GH-R gene mutation in Laron syndrome from different ethnic groups (abstract 217). GH IGF Res 2002;12:297.
20.
Blume-Peytavi U, Orfanos CE: Trichogram: Microscopy of the hair; in Seruo J, Jemec GBE (eds): Handbook of Non-Invasive Methods and the Skin. Boca Raton, CRC Press, 1995, pp 549–555.
21.
Reynolds AJ, Jahoda CAB: Cultured dermal papilla cells induce follicle formation and hair growth by transdifferentiation of an adult epidermis. Development 1992;115:587–593.
22.
Messenger AG: The control of hair growth: An overview. J Invest Dermatol 1993;101:4S–9S.
23.
Laron Z: Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab 2001;14:1243–1248.
24.
Whiting DA: Structural abnormalities of the hair shaft. J Am Acad Dermatol 1987;16:1–25.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.